Stocksigma LogoStocksigma Logo

Dr. Reddy's Confirms Voluntary Licensing Agreement with Gilead for HIV Drug

Dr. Reddy鈥檚 Laboratories confirmed on 18th Sep'26 that it entered into a voluntary licensing agreement with Gilead Sciences for investigational once-yearly

Dr. Reddy's Confirms Voluntary Licensing Agreement with Gilead for HIV Drug

Dr Reddys Laboratories Ltd 路 Others (Uncategorized) 路 18 Sept 2026, 2:11 pm

Dr. Reddy's Confirms Voluntary Licensing Agreement with Gilead for HIV Drug Dr. Reddy鈥檚 Laboratories confirmed on 18th Sep'26 that it entered into a voluntary licensing agreement with Gilead Sciences for investigational once-yearly lenacapavir used in HIV prevention, validating media reports from 17th Sep'26. Clarifying a query from BSE regarding trading movement, the company stated the agreement does not constitute a material event requiring separate disclosure under Regulation 30 of SEBI Listing Regulations, confirming there is no unannounced material information or ongoing regulatory proceedings.

Original exchange filing (PDF)

More announcements from Dr Reddys Laboratories Ltd

All Dr Reddys Laboratories Ltd announcements